Published in AIDS Weekly and Law, January 19th, 2006
Study 1: Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus (SHIV) 89.6p challenge in Mamu-A*01-negative rhesus monkeys.
"Simian-human immunodeficiency virus (SHIV) challenge studies in rhesus macaques were conducted to evaluate the efficacy of adenovirus-based vaccines in the context of different major histocompatibility complex class I genetic backgrounds and different vaccine compositions," researchers in the United States report.
"Mamu-A*01 allele-negative rhesus monkeys were immunized with one of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly and Law
Source: AIDS Weekly and Law (2006-01-19)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.